"Reshaping Vision, Lighting Up Lives" Public Welfare Rescue Project for Ocular Trauma and Retinal Detachment Officially Launched

Project Overview

• Sponsor: Ai Eye Public Welfare Foundation
• Supporting Unit: Guangzhou Vesber Biotechnology Co., Ltd.
• Implementation Period: May 1, 2025, to May 1, 2026
• Coverage: Expected to reach 31 provinces, autonomous regions, and municipalities across China, with a focus on remote areas with scarce medical resources.

Background and Significance

• Rhegmatogenous retinal detachment affects approximately 8 out of 100,000 people, with a high incidence.
• Nearly 50,000 patients undergo eyeball enucleation each year due to severe ocular trauma, imposing heavy physical and mental burdens on families.
  Traditional treatments face challenges like silicone oil complications and repeated surgeries. Innovations such as the Foldable Capsular Vitreous Body (FCVB) and Foldable Capsular Buckle (FCB) developed by Professor Gao Qianying’s team offer new hope, preventing enucleation and calling for broader support.

Project Initiatives

1. Financial Aid: Subsidize partial surgical costs for eligible patients with ocular trauma or retinal detachment.
2. Public Awareness Campaigns: Promote eye health education and free screening clinics to enhance ocular care awareness nationwide, aligning with China’s Healthy China initiative.

Partners’ Profiles

Ai Eye Public Welfare Foundation

• Over 1,000,000 rescue surgeries for patients.
• Benefited nearly 200 million people through public services.
• Honors: National Advanced Social Organization, 5A-rated Charity, United Nations ECOSOC Special Consultative Status, etc.

Guangzhou Vesber Biotechnology Co., Ltd.

• Core Products: Foldable Capsular Vitreous Body (FCVB), Silicone Scleral Buckle (SSB), Foldable Capsular Buckle (FCB), High Myopia Posterior Scleral Reinforcement System (HM), etc.
• Milestones:
  • FCVB listed as one of the world’s top 4 advancements in retinal detachment surgery (2013).
  • Awarded Guangdong Provincial High-Tech Product, National High-Tech Enterprise, and multiple science and technology awards.
  • Global R&D center in Duisburg, Germany, connecting with international ophthalmology experts.

Innovative Ophthalmic Technologies

Foldable Capsular Vitreous Body (FCVB)

• Design: Mimics the natural vitreous cavity with medical-grade silicone, featuring a balloon, drainage tube, valve, and fixing loops.
• Function: Implanted folded into the vitreous cavity, filled with silicone oil to support the retina, maintain intraocular pressure, and prevent silicone oil migration/complications.
• Goal: Preserve the eyeball, avoid enucleation, and restore vision.

Foldable Capsular Buckle (FCB)

• Minimally Invasive Approach: Implanted subconjunctivally, inflated with saline to "lift" the detached retina like a jack.
• Advantages:
  • 5 "No"s: No retrobulbar anesthesia, no muscle traction, no scleral fluid drainage, no intraoperative localization, no cryotherapy.
  • Shorter surgery time (10 minutes vs. 50 minutes traditionally), broader tamponade range, less pain, and fewer complications.

 Commitment to Innovation and Public Welfare